Alabed S, Zhou H, Sariyer IK, Chang SL (2021) Meta-analysis of methamphetamine modulation on amyloid precursor protein through HMGB1 in Alzheimer’s disease. Int J Mol Sci 22:4781

CAS  PubMed  PubMed Central  Google Scholar 

Arai H, Lee VM, Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ (1991) Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer’s disease and control subjects. Ann Neurol 30:686–693

CAS  PubMed  Google Scholar 

Biffi A, Greenberg SM (2011) Cerebral amyloid angiopathy: a systematic review. J Clin Neurol 7:1

PubMed  PubMed Central  Google Scholar 

Bossù P, Toppi E, Sterbini V, Spalletta G (2020) Implication of aging related chronic neuroinflammation on COVID-19 pandemic. J Pers Med 10:102

PubMed Central  Google Scholar 

d’Uscio LV, He T, Santhanam AV, Katusic ZS (2018) Endothelium-specific amyloid precursor protein deficiency causes endothelial dysfunction in cerebral arteries. J Cereb Blood Flow Metab 38:1715–1726

PubMed  Google Scholar 

de Paula VJR, Guimaraes FM, Diniz BS, Forlenza OV (2009) Neurobiological pathways to Alzheimer’s disease: amyloid-beta, TAU protein or both? Dement Neuropsychol 3:188–194

PubMed  PubMed Central  Google Scholar 

Deane R et al (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9:907–913

CAS  PubMed  Google Scholar 

d’Uscio LV, He T, Katusic ZS (2017) Expression and processing of amyloid precursor protein in vascular endothelium. Physiology 32:20–32

CAS  PubMed  Google Scholar 

Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T (2020) Neurological associations of COVID-19. Lancet Neurol 19:767–783

CAS  PubMed  PubMed Central  Google Scholar 

Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W (2011) Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis 2:e167

CAS  PubMed  PubMed Central  Google Scholar 

Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J-C, Turner AJ, Raizada MK, Grant MB, Oudit GY (2020) Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the Renin-Angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res 126:1456–1474

CAS  PubMed  Google Scholar 

Ghiso J, Fossati S, Rostagno A (2014) Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells. JAD 42:S167–S176

PubMed  Google Scholar 

Huang C et al (2021a) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet 397:220–232

CAS  Google Scholar 

Huang W, Zhou H, Hodgkinson C, Montero A, Goldman D, Chang SL (2021b) Network meta-analysis on the mechanisms underlying alcohol augmentation of COVID-19 pathologies. Alcohol Clin Exp Res 45:675–688

CAS  PubMed  Google Scholar 

Kaneko N, Satta S, Komuro Y, Muthukrishnan SD, Kakarla V, Guo L, An J, Elahi F, Kornblum HI, Liebeskind DS, Hsiai T, Hinman JD (2021) Flow-mediated susceptibility and molecular response of cerebral endothelia to SARS-CoV-2 infection. Stroke 52:260–270

CAS  PubMed  Google Scholar 

Kennedy M et al (2020) Delirium in older patients with COVID-19 presenting to the emergency department. JAMA Netw Open 3:e2029540

PubMed  PubMed Central  Google Scholar 

Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement (n y) 4:575–590

Google Scholar 

Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s disease. J Neurosci 25:8843–8853

CAS  PubMed  PubMed Central  Google Scholar 

Kramer A, Green J, Pollard J Jr, Tugendreich S (2014) Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30:523–530

PubMed  PubMed Central  Google Scholar 

Li YC, Bai WZ, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92:552–555

CAS  PubMed  Google Scholar 

Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS (2004) Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem 279:49523–49532

CAS  PubMed  Google Scholar 

McManus RM, Heneka MT (2017) Role of neuroinflammation in neurodegeneration: new insights. Alzheimers Res Ther 9:14–14

PubMed  PubMed Central  Google Scholar 

Merkler AE et al (2020) Risk of Ischemic stroke in patients with Coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol 77:1366

Google Scholar 

Miners S, Kehoe PG, Love S (2020) Cognitive impact of COVID-19: looking beyond the short term. Alz Res Therapy 12:170

CAS  Google Scholar 

Montagna E, Dorostkar MM, Herms J (2017) The role of APP in structural spine plasticity. Front Mol Neurosci 10:136

PubMed  PubMed Central  Google Scholar 

Nunan J, Small DH (2000) Regulation of APP cleavage by α-, β- and γ-secretases. FEBS Lett 483:6–10

CAS  PubMed  Google Scholar 

Obermeier B, Daneman R, Ransohoff RM (2013) Development, maintenance and disruption of the blood-brain barrier. Nat Med 19:1584–1596

CAS  PubMed  PubMed Central  Google Scholar 

Organization GWH (2020) WHO COVID-19 Dashboard. In.

Puig KL, Combs CK (2013) Expression and function of APP and its metabolites outside the central nervous system. Exp Gerontol 48:608–611

CAS  PubMed  Google Scholar 

Rahman MA, Islam K, Rahman S, Alamin M (2021) Neurobiochemical cross-talk between COVID-19 and Alzheimer’s disease. Mol Neurobiol 58:1017–1023

CAS  PubMed  Google Scholar 

Reynolds JL, Mahajan SD (2021) SARS-COV2 alters blood brain barrier integrity contributing to neuro-inflammation. J Neuroimmune Pharmacol 16:4–6

PubMed  Google Scholar 

Ristori E, Donnini S, Ziche M (2020) New insights into blood–brain barrier maintenance: the homeostatic role of β-amyloid precursor protein in cerebral vasculature. Front Physiol 11:1056

PubMed  PubMed Central  Google Scholar 

Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI (1994) Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 57:419–425

CAS  PubMed  PubMed Central  Google Scholar 

Robinson PC, Liew DFL, Liew JW, Monaco C, Richards D, Shivakumar S, Tanner HL, Feldmann M (2020) The potential for repurposing anti-TNF as a therapy for the treatment of COVID-19. Med 1:90–102

PubMed  Google Scholar 

Shang J, Yamashita T, Tian F, Li X, Liu X, Shi X, Nakano Y, Tsunoda K, Nomura E, Sasaki R, Tadokoro K, Sato K, Takemoto M, Hishikawa N, Ohta Y, Abe K (2019) Chronic cerebral hypoperfusion alters amyloid-beta transport related proteins in the cortical blood vessels of Alzheimer’s disease model mouse. Brain Res 1723:146379

CAS  PubMed  Google Scholar 

Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, Bucci E, Piacentini M, Ippolito G, Melino G (2020) COVID-19 infection: the perspectives on immune responses. Cell Death Differ 27:1451–1454

CAS  PubMed  PubMed Central  Google Scholar 

Stouffer SA, Suchman EA, Devinney LC, Star SA, Williams RM Jr (1949) The American soldier: Adjustment during army life (Studies in social psychology in World War II), vol 1. Princeton Univ. Press, Oxford

Google Scholar 

Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8:416–427

PubMed  PubMed Central  Google Scholar 

Tian W, Zhang N, Jin R, Feng Y, Wang S, Gao S, Gao R, Wu G, Tian D, Tan W, Chen Y, Gao GF, Wong CCL (2020) Immune suppression in the early stage of COVID-19 disease. Nat Commun 11:5859

CAS  PubMed  PubMed Central  Google Scholar 

Trougakos IP, Stamatelopoulos K, Terpos E, Tsitsilonis OE, Aivalioti E, Paraskevis D, Kastritis E, Pavlakis GN, Dimopoulos MA (2021) Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J Biomed Sci 28:9

CAS  PubMed  PubMed Central  Google Scholar 

Tu TM, Seet CYH, Koh JS, Tham CH, Chiew HJ, De Leon JA, Chua CYK, Hui AC-F, Tan SSY, Vasoo SS, Tan BY-Q, Umapathi NT, Tambyah PA, Yeo LLL (2021) Acute Ischemic stroke during the convalescent phase of asymptomatic COVID-2019 infection in men. JAMA Netw Open 4:e217498

PubMed  PubMed Central  Google Scholar 

Verdile G, Fuller S, Atwood CS, Laws SM, Gandy SE, Martins RN (2004) The role of beta amyloid in Alzheimer’s disease: still a cause of everything or the only one who got caught? Pharmacol Res 50:397–409

CAS  PubMed  Google Scholar 

Walters A, Phillips E, Zheng R, Biju M, Kuruvilla T (2016) Evidence for neuroinflammation in Alzheimer’s disease. Prog Neurol Psychiatry 20:25–31

Google Scholar 

WHITLOCK MC (2005) Combining probability from independent tests: the weighted Z-method is superior to Fisher’s approach. J Evol Biol 18:1368–1373

PubMed  Google Scholar 

Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 87:18–22

CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Rosenberg GA (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42:3323–3328

CAS  PubMed  PubMed Central  Google Scholar 

Yang C, Hawkins KE, Doré S, Candelario-Jalil E (2019) Neuroinflammatory mechanisms of blood–brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol 316:C135–C153

CAS  PubMed